Transcriptome Analysis in Human Breast Milk and Blood in a Randomized Trial after Inactivated or Attenuated Influenza Immunization
RNA-seq (gene expression) · human · 69 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 69 samples: 20 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281592_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1184762. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 57 samples.
How we read this: 20 replicated groups read from 69 sample titles; they account for 57 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8624207 Subject_G, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28
- GSM8624208 Subject_G, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624209 Subject_O, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28
- GSM8624210 Subject_O, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624211 Subject_I, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28
- GSM8624212 Subject_I, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624213 Subject_D, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28
- GSM8624214 Subject_D, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624215 Subject_M, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day8 Subject_M, trivalent in…
- GSM8624216 Subject_M, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day28 Subject_M, trivalent in…
- GSM8624217 Subject_M, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624218 Subject_K, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day8 Subject_K, trivalent in…
- GSM8624219 Subject_K, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day28 Subject_K, trivalent in…
- GSM8624220 Subject_K, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624221 Subject_H, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day2 Subject_H, live attenua…
- GSM8624222 Subject_H, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day8 Subject_H, live attenua…
- GSM8624223 Subject_H, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28 Subject_H, live attenua…
- GSM8624224 Subject_H, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624225 Subject_N, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day2 Subject_N, live attenua…
- GSM8624226 Subject_N, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day8 Subject_N, live attenua…
- GSM8624227 Subject_N, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28 Subject_N, live attenua…
- GSM8624228 Subject_N, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28
- GSM8624229 Subject_F, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day0 Subject_F, trivalent in…
- GSM8624230 Subject_F, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day8 Subject_F, trivalent in…
- GSM8624231 Subject_F, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day28 Subject_F, trivalent in…
- GSM8624232 Subject_F, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day0 Subject_F, trivalent in…
- GSM8624233 Subject_F, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day28 Subject_F, trivalent in…
- GSM8624234 Subject_E, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day0 Subject_E, trivalent in…
- GSM8624235 Subject_E, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day2 Subject_E, trivalent in…
- GSM8624236 Subject_E, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day8 Subject_E, trivalent in…
- GSM8624237 Subject_E, trivalent inactivated influenza vaccine (TIV), breast milk lymphocyte (BML), Day28 Subject_E, trivalent in…
- GSM8624238 Subject_E, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day0 Subject_E, trivalent in…
- GSM8624239 Subject_E, trivalent inactivated influenza vaccine (TIV), peripheral blood mononuclear cells (PBMC), Day28 Subject_E, trivalent in…
- GSM8624240 Subject_P, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day0 Subject_P, live attenua…
- GSM8624241 Subject_P, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day2 Subject_P, live attenua…
- GSM8624242 Subject_P, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day8 Subject_P, live attenua…
- GSM8624243 Subject_P, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day28 Subject_P, live attenua…
- GSM8624244 Subject_P, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day0 Subject_P, live attenua…
- GSM8624245 Subject_P, live attenuated influenza vaccine (LAIV), peripheral blood mononuclear cells (PBMC), Day28 Subject_P, live attenua…
- GSM8624246 Subject_A, live attenuated influenza vaccine (LAIV), breast milk lymphocyte (BML), Day0 Subject_A, live attenua…
+ 29 more — browse all 69 samples with per-sample file links →
- GSE271080 Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- primary breast cancer 86 samples shares randomized, breast, trial
- GSE252145 Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial 32 samples shares randomized, breast, trial
- GSE282132 Early immune responses in the lung and blood following a randomized controlled human inhaled infection with aerosolized attenuated Mycobacterium Bovis BCG in healthy, BCG-naïve, UK adults 12 samples shares randomized, attenuated, blood
- GSE266275 A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis 100 samples shares randomized, trial
- GSE240861 Ketogenicdiet versus standard high-carbohydrate nutrition in sepsis: a randomized controlled trial 100 samples shares randomized, trial
- GSE278745 The Effects of Refined Carbohydrates on Systemic Immunity: Results from a Randomized Controlled Feeding Trial 84 samples shares randomized, trial
- GSE298762 NSAIDS-XDR-TB clinical trial: A randomized pilot study to estimate the potential efficacy and safety of using adjunctive ibuprofen for the treatment of pre-XDR and XDR tuberculosis 73 samples shares randomized, trial
- GSE264314 Topical application of Urolithin A slows intrinsic skin aging and protects from UVB-mediated photodamage: Findings from Randomized Clinical Trials 57 samples shares randomized, trial
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.